Financials data is unavailable for this security.
View more
Year on year Infinium Pharmachem Ltd grew net income 19.10% from 94.90m to 113.02m primarily through revenue growth (1.14bn to 1.36bn). For while the costs associated with cost of goods, selling, general and administrative and debt all increased as a percentage of sales, the 18.75% growth in revenues contributed enough to still see net income improve.
| Gross margin | 23.99% |
|---|---|
| Net profit margin | 8.48% |
| Operating margin | 11.69% |
| Return on assets | 14.74% |
|---|---|
| Return on equity | 27.79% |
| Return on investment | 23.19% |
More ▼
Cash flow in INRView more
In 2024, Infinium Pharmachem Ltd increased its cash reserves by 99.19%, or 59.32m. Cash Flow from Financing totalled 227.70m or 16.79% of revenues. In addition the company used 130.44m for operations while cash used for investing totalled 37.94m.
| Cash flow per share | 10.18 |
|---|---|
| Price/Cash flow per share | 28.88 |
| Book value per share | 42.24 |
|---|---|
| Tangible book value per share | 42.24 |
More ▼
Balance sheet in INRView more
| Current ratio | 3.73 |
|---|---|
| Quick ratio | 2.18 |
| Total debt/total equity | 0.1913 |
|---|---|
| Total debt/total capital | 0.1573 |
More ▼
Growth rates in INR
Year on year, growth in earnings per share excluding extraordinary items dropped -13.00%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -13.00 |
